Shopping Cart 0
Cart Subtotal
USD 0

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

4SC AG (4SC) is a biopharmaceutical company that discovers and develops small molecule drugs for the treatment of cancer and autoimmune diseases. The company's product focuses on epigenetics, cancer stem cells and cancer immunotherapy. Its product pipeline comprises therapeutic programs at various stages of clinical development and early-stage research projects including Resminostat, 4SC-202 and 4SC-208. The company's research programs are related to cancer stem cells, ion channel blockers and cytokine modulation. It develops and markets products through partnerships with pharmaceutical and biotech companies. The company operates through its subsidiary 4SC Discovery GmbH. 4SC is headquartered in Bayern, Germany.

4SC AG Key Recent Developments

Mar 21,2018: 4SC announces results for financial year 2017

Jan 22,2018: 4SC strengthens patent protection for its Hedgehog/GLI signaling inhibitor 4SC-208

Oct 26,2017: 4SC provides Q3 and 9M 2017 update

Aug 10,2017: 4SC provides Q2 and 6M 2017 update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 - About the Company 5

4SC AG - Key Facts 5

4SC AG - Key Employees 6

4SC AG - Key Employee Biographies 7

4SC AG - Major Products and Services 8

4SC AG - History 9

4SC AG - Company Statement 12

4SC AG - Locations And Subsidiaries 15

Head Office 15

Section 2 - Company Analysis 16

Company Overview 16

4SC AG - Business Description 17

4SC AG - Corporate Strategy 18

4SC AG - SWOT Analysis 19

SWOT Analysis - Overview 19

4SC AG - Strengths 19

4SC AG - Weaknesses 20

4SC AG - Opportunities 21

4SC AG - Threats 22

4SC AG - Key Competitors 23

Section 3 - Company Financial Ratios 24

Financial Ratios - Capital Market Ratios 24

Financial Ratios - Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios - Interim Ratios 28

Financial Ratios - Ratio Charts 29

Section 4 - Company's Lifesciences Financial Deals and Alliances 30

4SC AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

4SC AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

4SC AG, Recent Deals Summary 32

Section 5 - Company's Recent Developments 33

Mar 21, 2018: 4SC announces results for financial year 2017 33

Jan 22, 2018: 4SC strengthens patent protection for its Hedgehog/GLI signaling inhibitor 4SC-208 34

Oct 26, 2017: 4SC provides Q3 and 9M 2017 update 35

Aug 10, 2017: 4SC provides Q2 and 6M 2017 update 36

Section 6 - Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41


List Of Figure

List of Figures

4SC AG, Performance Chart (2013 - 2017) 27

4SC AG, Ratio Charts 29

4SC AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

4SC AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31


List Of Table

List of Tables

4SC AG, Key Facts 5

4SC AG, Key Employees 6

4SC AG, Key Employee Biographies 7

4SC AG, Major Products and Services 8

4SC AG, History 9

4SC AG, Key Competitors 23

4SC AG, Ratios based on current share price 24

4SC AG, Annual Ratios 25

4SC AG, Annual Ratios (Cont...1) 26

4SC AG, Interim Ratios 28

4SC AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

4SC AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

4SC AG, Recent Deals Summary 32

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

4SC AG, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

SWOG

MediGene AG

Galapagos NV

Biovest International Inc

Apitope International NV